Cross-Center Validation of Deep Learning Model for Musculoskeletal Fracture Detection in Radiographic Imaging: A Feasibility Study

Competing Interest Statement

Robert Hruby is an employee of Carebot s.r.o. Daniel Kvak is an employee of Carebot s.r.o. Jakub Dandar, MD is an employee of Carebot s.r.o. Anora Atakhanova is an employee of Carebot s.r.o. Matěj Misar is an employee of Carebot s.r.o. Daniel Dufek is an employee of Carebot s.r.o.

Funding Statement

This study was funded by Carebot s.r.o.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study uses MURA dataset, presented in "MURA: Large Dataset for Abnormality Detection in Musculoskeletal Radiographs" (https://arxiv.org/abs/1712.06957), FracAtlas dataset, presented in "FracAtlas: A Dataset for Fracture Classification, Localization and Segmentation of Musculoskeletal Radiographs" (https://www.nature.com/articles/s41597-023-02432-4), and internal dataset from Carebot s.r.o., which is available upon written request. This study was enabled by contract for the transfer of X-ray images for medical research purposes (Smlouva o predani skiagrafickych snimku pro ucely medicinskeho vyzkumu) between Nemocnice Sumperk, a.s. and Carebot s.r.o., signed on 14 December 2023 in Prague, Czech Republic. The Ethics Committee of Nemocnice Sumperk, a.s approved the transfer of patient studies for the research project. Patient consent was waived due to Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and the repealing of Directive 95/46/EC (General Data Protection Regulation); i.e., the images were stripped of all direct or indirect identifiers without the possibility of retrospective patient identification.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes